Effects of the Hepatic Lipase Gene and Physical Activity on Coronary Heart Disease Risk

American Journal of Epidemiology

Volumn 158, Issue 9, 2003, Pages 836-843

  Hokanson, John E ^a   Kamboh, M Ilyas ^b   Scarboro, Sharon ^a   Eckel, Robert H ^a   Hamman, Richard F ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cohort studies; Coronary disease; Genetic predisposition to disease; Polymorphism (genetics); Risk factors

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE;

CARDIOVASCULAR DISEASE; DISEASE PREVALENCE; HEALTH RISK; RISK FACTOR;

ADULT; ARTICLE; CARDIOVASCULAR RISK; CAUCASIAN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HEPATIC LIPASE GENE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ADULT; AGED; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; CORONARY DISEASE; EXERCISE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LIPASE; LIPIDS; LIVER; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROSPECTIVE STUDIES; RISK FACTORS;

EID: 0142157175     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg230     Document Type: Article

References (43)

1. American Heart Association. Heart and stroke facts, 1998. Dallas, TX: American Heart Association, 1998.
2. Hoeg JM. Evaluating coronary heart disease risk. Tiles in the mosaic. JAMA 1997;277:1387-90.
3. Despres JP, Lamarche B. Low-intensity endurance exercise training, plasma lipoproteins and the risk of coronary heart disease. J Intern Med 1994;236:7-22.
4. Gordon DJ, Witztum JL, Hunninghake D, et al. Habitual physical activity and high-density lipoprotein cholesterol in men with primary hypercholesterolemia. The Lipid Research Clinics Coronary Primary Prevention Trial. Circulation 1983;67:512-20.
5. Paffenbarger RS Jr, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1995;142:889-903.
6. Peters RK, Cady LD Jr, Bischoff DP, et al. Physical fitness and subsequent myocardial infarction in healthy workers. JAMA 1983;249:3052-6.
7. Salonen JT, Slater JS, Tuomilehto J, et al. Leisure time and occupational physical activity: risk of death from ischemic heart disease. Am J Epidemiol 1988;127:87-94.
8. Williams PT. Physical fitness and activity as separate heart disease risk factors: a meta-analysis. Med Sci Sports Exerc 2001;33:754-61.
9. Couillard C, Despres JP, Lamarche B, et al. Effects of endurance exercise training on plasma HDL cholesterol levels depend on levels of triglycerides: evidence from men of the Health, Risk Factors, Exercise Training and Genetics (HERITAGE) Family Study. Arterioscler Thromb Vasc Biol 2001;21:1226-32.
10. Goldstein JL, Hobbs HH, Brown MS. Familial hyper-cholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, et al, eds. The metabolic basis of inherited diseases. New York, NY: McGraw-Hill, 1995:1981-2030.
11. Auwerx JH, Marzetta CA, Hokanson JE, et al. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis 1989;9:319-25.
12. 2 in man. Atherosclerosis 1980;36:589-93.
13. Zambon A, Austin MA, Brown BG, et al. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscler Thromb 1993;13:147-53.
14. Zambon A, Deeb SS, Bensadoun A, et al. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J Lipid Res 2000;41:2094-9.
15. Giada F, Baldo-Enzi G, Baiocchi MR, et al. Specialized physical training programs: effects on serum lipoprotein cholesterol, apoproteins A-I and B and lipolytic enzyme activities. J Sports Med Phys Fitness 1991;31:196-203.
16. Mendoza SG, Carrasco H, Zerpa A, et al. Effect of physical training on lipids, lipoproteins, apolipoproteins, lipases, and endogenous sex hormones in men with premature myocardial infarction. Metabolism 1991;40:368-77.
17. Leon AS, Gaskill SE, Rice T, et al. Variability in the response of HDL cholesterol to exercise training in the HERITAGE Family Study. Int J Sports Med 2002;23:1-9.
18. Carr MC, Hokanson JE, Deeb SS, et al. A hepatic lipase gene promoter polymorphism attenuates the increase in hepatic lipase activity with increasing intra-abdominal fat in women. Arterioscler Thromb Vasc Biol 1999;19:2701-7.
19. Hokanson JE, Hamman RF, Eckel RH, et al. Gene-environment interaction in the regulation of HDL: the hepatic lipase promoter polymorphism modulates the physical activity associated increase in HDL. (Abstract). Circulation 2001;103:P08.
20. Fan Y, Laaksonen R, Janatuinen T, et al. Hepatic lipase gene variation is related to coronary reactivity in healthy young men. Eur J Clin Invest 2001;31:574-80.
21. Hokanson JE, Cheng S, Snell-Bergeon JK, et al. A common polymorphism in the hepatic lipase gene (LIPC-480 C>T) is associated with an increase in coronary artery calcification in type 1 diabetes. Diabetes 2002;51:1208-13.
22. Dugi KA, Brandauer K, Schmidt N, et al. Low hepatic lipase activity is a novel risk factor for coronary artery disease. Circulation 2001;104:3057-62.
23. Jansen H, Verhoeven AJ, Weeks L, et al. Common C-to-T substitution at position-480 of the hepatic lipase promoter associated with a lowered lipase activity in coronary artery disease patients. Arterioscler Thromb Vasc Biol 1997;17:2837-42.
24. Ji J, Herbison CE, Mamotte CD, et al. Hepatic lipase gene-514 C/T polymorphism and premature coronary heart disease. J Cardiovasc Risk 2002;9:105-13.
25. Hamman RF, Marshall JA, Baxter J, et al. Methods and prevalence of non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1989;129:295-311.
26. Guerra R, Wang J, Grundy SM, et al. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A 1997;94:4532-7.
27. Cal SJ, Wong DM, Chen SH, et al. Structure of the human hepatic triglyceride lipase gene. Biochemistry 1989;28:8966-71.
28. Mayer EJ, Alderman BW, Regensteiner JG, et al. Physical-activity-assessment measures compared in a biethnic rural population: the San Luis Valley Diabetes Study. Am J Clin Nutr 1991;53:812-20.
29. Rewers M, Shetterly SM, Hoag S, et al. Is the risk of coronary heart disease lower in Hispanics than in non-Hispanic whites? The San Luis Valley Diabetes Study. Ethn Dis 1993;3:44-54.
30. Rewers M, Shetterly SM, Baxter J, et al. Prevalence of coronary heart disease in subjects with normal and impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a biethnic Colorado population. The San Luis Valley Diabetes Study. Am J Epidemiol 1992;135:1321-30.
31. Hokanson JE, Austin MA. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-19.
32. Hokanson JE. Hypertriglyceridemia and risk of coronary heart disease. Curr Cardiol Rep 2002;4:488-93.
33. 2 cholesterol. Arterioscler Thromb Vasc Biol 1998;18:1723-9.
34. Jansen H, Chu G, Ehnholm C, et al. The T allele of the hepatic lipase promoter variant C-480T is associated with increased fasting lipids and HDL and increased preprandial and postprandial LpCIII:B: European Atherosclerosis Research Study (EARS) II. Arterioscler Thromb Vasc Biol 1999;19:303-8.
35. Santamarina-Fojo S, Haudenschild C, Amar M. The role of hepatic lipase in lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol 1998;9:211-19.
36. Huff MW, Miller DB, Wolfe BM, et al. Uptake of hypertriglyceridemic very low density lipoproteins and their remnants by HepG2 cells: the role of lipoprotein lipase, hepatic triglyceride lipase, and cell surface proteoglycans. J Lipid Res 1997;38:1318-33.
37. Tahvanainen E, Syvanne M, Frick MH, et al. Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT Study Investigators. J Clin Invest 1998;101:956-60.
38. Krauss RM, Lindgren FT, Williams PT, et al. Intermediate-density lipoproteins and progression of coronary artery disease in hypercholesterolaemic men. Lancet 1987;2:62-6.
39. Steiner G, Schwartz L, Shumak S, et al. The association of increased levels of intermediate-density lipoproteins with smoking and with coronary artery disease. Circulation 1987;75:124-30.
40. Shohet RV, Vega GL, Anwar A, et al. Hepatic lipase (LIPC) promoter polymorphism in men with coronary artery disease. Allele frequency and effects on hepatic lipase activity and plasma HDL-C concentrations. Arterioscler Thromb Vasc Biol 1999;19:1975-8.
41. Czernin J, Sun K, Brunken R, et al. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995;91:2891-7.
42. Vogel RA, Corretti MC, Plotnick GD. Effect of a single high-fat meal on endothelial function in healthy subjects. Am J Cardiol 1997;79:350-4.
43. Nie L, Wang J, Clark LT, et al. Body mass index and hepatic lipase gene (LIPC) polymorphism jointly influence postheparin plasma hepatic lipase activity. J Lipid Res 1998;39:1127-30.